{"disease":{"id":"psma-pet-positive-castration-resistant-prostate-cancer","name":"psma pet positive castration resistant prostate cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06850545","title":"Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT06809426","title":"Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Affiliated Hospital of Jiangnan University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}